Editas Medicine, Inc. (EDIT) director reports no share or option holdings

Rhea-AI Filing Summary

Editas Medicine, Inc. reports that Ellinor Patrick Thomas II is a director and reporting insider on an initial beneficial ownership report. The disclosure shows no reported holdings of common stock or derivative securities and no purchase, sale, option exercise, gift, or other insider transaction activity associated with this person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Available on EDGAR 08/07/2026 - 05:16 PM Accepted by SEC EDGAR 08/07/2026 - 05:15 PM Learn about SEC filing dates

FAQ

What does Editas Medicine (EDIT) report about Ellinor Patrick Thomas II in this Form 3?

Ellinor Patrick Thomas II is identified as a director and reporting insider of Editas Medicine, Inc. The report lists no holdings of common stock or derivative securities and no insider transaction activity tied to this individual.

Does the Editas Medicine (EDIT) Form 3 show any share purchases or sales by Ellinor Patrick Thomas II?

No. The Form 3 for Ellinor Patrick Thomas II shows zero reported transactions. There are no purchases, sales, option exercises, gifts, or other insider trades disclosed in connection with this reporting person.

What equity holdings does Editas Medicine (EDIT) attribute to Ellinor Patrick Thomas II?

The report does not show any common stock or derivative securities holdings for Ellinor Patrick Thomas II. Holding entries are reported as zero, indicating no beneficial ownership positions are disclosed in this document.

Is there any Rule 10b5-1 trading plan indicated for Ellinor Patrick Thomas II at Editas Medicine (EDIT)?

No. The document’s Rule 10b5-1 plan indicator is null, and there are no footnotes describing a trading plan. Combined with zero reported transactions, this suggests no disclosed pre-arranged trading activity for this insider.

What insider role does Ellinor Patrick Thomas II hold at Editas Medicine (EDIT)?

Ellinor Patrick Thomas II is reported as a director of Editas Medicine, Inc. He is not flagged as an officer or as a ten percent owner, so his insider status in this report is based on his role as a director.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Ellinor Patrick Thomas II

(Last) (First) (Middle)

11 HURLEY STREET

(Street)

CAMBRIDGE MASSACHUSETTS 02141

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
08/06/2026

3. Issuer Name and Ticker or Trading Symbol
Editas Medicine, Inc. [ EDIT ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

No securities are beneficially owned.

	/s/ Patrick Ellinor	08/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)